TARGETING RB LOSS USING BET INHIBITION TO REPROGRAM THE PROSTATE TUMOR MICROENVIRONMENT AND ENHANCE THE EFFICACY OF IMMUNOTHERAPY

Emory University, Atlanta GA

Investigators